Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.
Surface IgM (sIgM) was increased up to 10 times on human tonsillar B cells activated with IL-4. No change was observed for surface IgD, IgG or IgE. Other activators of human B cells, such as TPA, EBV and anti-IgM resulted in increased expression of the low-affinity receptor for IgE (CD23), but had no effect on sIgM. IL-4 also increased sIgM expression on prolymphocytic leukaemic (PLL) B cells, whereas TPA significantly reduced the level of sIgM. The effect on sIgM thus seems specific for IL-4, and is consistent with the existence of a unique IL-4-dependent B-cell activation pathway. Preincubation with IL-4 did not 'prime' B cells to proliferate in response to subsequent exposure to anti-IgM, and slightly decreased the response to co-stimulation with IL-4 and anti-IgM. The increase in sIgM expression in response to IL-4, therefore, does not seem to be important for proliferation.
14 references, click to expand
-
Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.J Exp Med. 1987 Jan 1;165(1):268-73 PMID: 3491870
-
B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.J Immunol. 1987 Jul 1;139(1):135-41 PMID: 3108395
-
Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.J Exp Med. 1987 Jun 1;165(6):1459-67 PMID: 2953844
-
Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.J Immunol. 1988 Mar 1;140(5):1425-30 PMID: 3257976
-
Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40).Eur J Immunol. 1988 Mar;18(3):349-53 PMID: 2965643
-
Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.Immunology. 1986 Aug;58(4):583-9 PMID: 2426188
-
B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide.J Exp Med. 1986 Aug 1;164(2):517-31 PMID: 3487616
-
An improved rosetting assay for detection of human T lymphocytes.J Immunol Methods. 1974 Jul;5(2):131-5 PMID: 4600315
-
The primary structure of a human IgG2 heavy chain: genetic, evolutionary, and functional implications.J Immunol. 1980 Sep;125(3):1048-54 PMID: 6774012
-
Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.Proc Natl Acad Sci U S A. 1984 Oct;81(19):6149-53 PMID: 6435125
-
B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.Proc Natl Acad Sci U S A. 1985 Apr;82(8):2465-7 PMID: 3873068
-
B-cell stimulatory factor 1 activates resting B cells.Proc Natl Acad Sci U S A. 1985 May;82(9):2935-9 PMID: 3873071
-
Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1.J Exp Med. 1985 Nov 1;162(5):1726-31 PMID: 3932582
-
BSF1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes.J Immunol. 1986 Dec 1;137(11):3664-70 PMID: 3023486
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
